114 related articles for article (PubMed ID: 11106643)
21. Functional interactions between arginine-133 and aspartate-88 in the human reduced folate carrier: evidence for a charge-pair association.
Liu XY; Matherly LH
Biochem J; 2001 Sep; 358(Pt 2):511-6. PubMed ID: 11513752
[TBL] [Abstract][Full Text] [Related]
22. Isolation of human cDNAs that restore methotrexate sensitivity and reduced folate carrier activity in methotrexate transport-defective Chinese hamster ovary cells.
Wong SC; Proefke SA; Bhushan A; Matherly LH
J Biol Chem; 1995 Jul; 270(29):17468-75. PubMed ID: 7615551
[TBL] [Abstract][Full Text] [Related]
23. Reduced folate carrier gene expression in childhood acute lymphoblastic leukemia: relationship to immunophenotype and ploidy.
Zhang L; Taub JW; Williamson M; Wong SC; Hukku B; Pullen J; Ravindranath Y; Matherly LH
Clin Cancer Res; 1998 Sep; 4(9):2169-77. PubMed ID: 9748136
[TBL] [Abstract][Full Text] [Related]
24. Oligomeric structure of the human reduced folate carrier: identification of homo-oligomers and dominant-negative effects on carrier expression and function.
Hou Z; Matherly LH
J Biol Chem; 2009 Jan; 284(5):3285-3293. PubMed ID: 19019821
[TBL] [Abstract][Full Text] [Related]
25. Prognostic role of the reduced folate carrier, the major membrane transporter for methotrexate, in childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Ge Y; Haska CL; LaFiura K; Devidas M; Linda SB; Liu M; Thomas R; Taub JW; Matherly LH
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):451-7. PubMed ID: 17255265
[TBL] [Abstract][Full Text] [Related]
26. Localization of a substrate binding domain of the human reduced folate carrier to transmembrane domain 11 by radioaffinity labeling and cysteine-substituted accessibility methods.
Hou Z; Stapels SE; Haska CL; Matherly LH
J Biol Chem; 2005 Oct; 280(43):36206-13. PubMed ID: 16115875
[TBL] [Abstract][Full Text] [Related]
27. Transcriptional regulation of the human reduced folate carrier A1/A2 promoter: Identification of critical roles for the USF and GATA families of transcription factors.
Payton SG; Liu M; Ge Y; Matherly LH
Biochim Biophys Acta; 2005 Nov; 1731(2):115-24. PubMed ID: 16225938
[TBL] [Abstract][Full Text] [Related]
28. Identification of the minimal functional unit of the homo-oligomeric human reduced folate carrier.
Hou Z; Cherian C; Drews J; Wu J; Matherly LH
J Biol Chem; 2010 Feb; 285(7):4732-40. PubMed ID: 20018840
[TBL] [Abstract][Full Text] [Related]
29. Impaired membrane transport in methotrexate-resistant CCRF-CEM cells involves early translation termination and increased turnover of a mutant reduced folate carrier.
Wong SC; Zhang L; Witt TL; Proefke SA; Bhushan A; Matherly LH
J Biol Chem; 1999 Apr; 274(15):10388-94. PubMed ID: 10187828
[TBL] [Abstract][Full Text] [Related]
30. The reduced folate carrier gene is a novel selectable marker for recombinant protein overexpression.
Rothem L; Berman B; Stark M; Jansen G; Assaraf YG
Mol Pharmacol; 2005 Sep; 68(3):616-24. PubMed ID: 15939798
[TBL] [Abstract][Full Text] [Related]
31. Identification of dynein light chain road block-1 as a novel interaction partner with the human reduced folate carrier.
Ashokkumar B; Nabokina SM; Ma TY; Said HM
Am J Physiol Gastrointest Liver Physiol; 2009 Sep; 297(3):G480-7. PubMed ID: 19571232
[TBL] [Abstract][Full Text] [Related]
32. Relationship of p15 and p16 gene alterations to elevated dihydrofolate reductase in childhood acute lymphoblastic leukaemia.
Shah SJ; Taub JW; Witt TL; Pollock BH; Ding BC; Moore DS; Amylon M; Pullen J; Ravindranath Y; Matherly LH
Br J Haematol; 2001 Jun; 113(3):746-56. PubMed ID: 11380466
[TBL] [Abstract][Full Text] [Related]
33. Intracellular trafficking and membrane targeting mechanisms of the human reduced folate carrier in Mammalian epithelial cells.
Marchant JS; Subramanian VS; Parker I; Said HM
J Biol Chem; 2002 Sep; 277(36):33325-33. PubMed ID: 12087110
[TBL] [Abstract][Full Text] [Related]
34. Characterization of a cysteine-less human reduced folate carrier: localization of a substrate-binding domain by cysteine-scanning mutagenesis and cysteine accessibility methods.
Cao W; Matherly LH
Biochem J; 2003 Aug; 374(Pt 1):27-36. PubMed ID: 12749765
[TBL] [Abstract][Full Text] [Related]
35. p14ARF expression increases dihydrofolate reductase degradation and paradoxically results in resistance to folate antagonists in cells with nonfunctional p53.
Magro PG; Russo AJ; Li WW; Banerjee D; Bertino JR
Cancer Res; 2004 Jun; 64(12):4338-45. PubMed ID: 15205349
[TBL] [Abstract][Full Text] [Related]
36. Transcript heterogeneity of the human reduced folate carrier results from the use of multiple promoters and variable splicing of alternative upstream exons.
Zhang L; Wong SC; Matherly LH
Biochem J; 1998 Jun; 332 ( Pt 3)(Pt 3):773-80. PubMed ID: 9620882
[TBL] [Abstract][Full Text] [Related]
37. Comparison of methotrexate polyglutamylation in L1210 leukemia cells when influx is mediated by the reduced folate carrier or the folate receptor. Lack of evidence for influx route-specific effects.
Spinella MJ; Brigle KE; Freemantle SJ; Sierra EE; Goldman ID
Biochem Pharmacol; 1996 Sep; 52(5):703-12. PubMed ID: 8765468
[TBL] [Abstract][Full Text] [Related]
38. Methylation-dependent silencing of the reduced folate carrier gene in inherently methotrexate-resistant human breast cancer cells.
Worm J; Kirkin AF; Dzhandzhugazyan KN; Guldberg P
J Biol Chem; 2001 Oct; 276(43):39990-40000. PubMed ID: 11509559
[TBL] [Abstract][Full Text] [Related]
39. Clustering of mutations in the first transmembrane domain of the human reduced folate carrier in GW1843U89-resistant leukemia cells with impaired antifolate transport and augmented folate uptake.
Drori S; Jansen G; Mauritz R; Peters GJ; Assaraf YG
J Biol Chem; 2000 Oct; 275(40):30855-63. PubMed ID: 10899164
[TBL] [Abstract][Full Text] [Related]
40. Stereoselective transport of human His27- and Arg27-reduced folate carrier.
Narawa T; Yanagisawa H; Itoh T
Biol Pharm Bull; 2014; 37(3):439-46. PubMed ID: 24583862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
